Impairment of lung function, health status and functional capacity in patients with ANCA-associated vasculitis

Rheumatology

Volumn 44, Issue 5, 2005, Pages 623-628

  Newall, C ^a   Schinke, S ^a   Savage, C O ^a   Hill, S ^a   Harper, L ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

ANCA associated vasculitis; Exercise; Lung; Quality of life

Indexed keywords

PREDNISOLONE; STEROID; TRANSFER FACTOR; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; AIRWAY OBSTRUCTION; ANCA ASSOCIATED VASCULITIS; ARTICLE; BREATHING MUSCLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG USE; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; GAS DIFFUSION; HEALTH STATUS; HUMAN; LUNG DISEASE; LUNG FUNCTION TEST; MALE; MENTAL HEALTH; MUSCLE STRENGTH; OXYGEN SUPPLY; PREDICTION; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; QUESTIONNAIRE; REMISSION; RESIDUAL VOLUME; RESPIRATORY TRACT PARAMETERS; SHORT FORM 36; SKELETAL MUSCLE; THORAX RADIOGRAPHY; TREADMILL EXERCISE; AUTOIMMUNE DISEASE; EXERCISE TEST; HEALTH SURVEY; IMMUNOLOGY; LUNG; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PILOT STUDY; QUALITY OF LIFE; VASCULITIS;

ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOIMMUNE DISEASES; EXERCISE TEST; FEMALE; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; LUNG; LUNG DISEASES; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PILOT PROJECTS; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; RESPIRATORY MUSCLES; VASCULITIS;

EID: 21244471527     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keh548     Document Type: Article

References (23)

1. Savage COS, Harper L, Adu D. Primary systemic vasculitis. Lancet 1997;349:553-8.
2. Hogan S, Nachman P, Wilkman A, Jennette J, Falk R. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996;7:23-32.
3. Schwarz MI, Mortenson RL, Colby TV et al. Pulmonary capillaritis. The association with progressive irreversible airflow limitation and hyperinflation. Am Rev Respir Dis 1993;148:507-11.
4. Brugiere O, Raffy O, Sleiman C et al. Progressive obstructive lung disease associated with microscopic polyangiitis. Am J Respir Crit Care Med 1997;155:739-42.
5. Nada AK, Torres VE, Ryu JH, Lie JT, Holley KE. Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary-renal vasculitis in elderly patients. Mayo Clin Proc 1990;65:847-56.
6. Rosenberg D, Weinberger S, Fulmer J, Flye M, Fauci A, Crystal R. Functional correlates of lung involvement in Wegener's granulomatosis. Use of pulmonary function tests in staging and follow-up. Am J Med 1980;69:387-94.
7. Jayne D, Rasmussen N, Andrassy K et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003;349:36-44.
8. Jayne D. Current attitudes to the therapy of vasculitis. Kidney Blood Press Res 2003;26:231-9.
9. Decramer M, Lacquet LM, Fagard R, Rogiers P. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med 1994;150:11-6.
10. Hutchison DC RS, Allen M, Hill SL, Kendrick AH, Miller MR, Morgan MD. Guidelines for the measurement of respiratory function. Respir Med 1994;88:165-194.
11. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party. Standardisation of Lung Function Tests, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J 1993(Suppl. 16):5-40.
12. Al-Rawas OA, Carter R, Stevenson RD, Naik SK, Wheatley DJ. The alveolar-capillary membrane diffusing capacity and the pulmonary capillary blood volume in heart transplant candidates. Heart 2000;83:156-60.
13. Roughton FJ, Forster RE. Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries. J Appl Physiol 1957;11:290-302.
14. Cotes J. Lung function throughout life: Determinants and reference values. In: Coxes JE, eA. Lung function: assessment and applications in medicine. Oxford: Blackwell Scientific Publications, 1993;445-513.
15. Borg G. A category scale with ratio properties for intermodal and interindividual comparisons. In: Geissler H, Petzold P, eds. Psychophysical judgement and the process of perception. 1984; 25-34.
16. Jones N. Clinical exercise testing. W.B. Saunders, 1988.
17. Keyser RE, Rus V, Cade WT, Kalappa N, Flores RH, Handwerger BS. Evidence for aerobic insufficiency in women with systemic lupus erythematosus. Arthritis Rheum 2003;49:16-22.
18. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145:1321-7.
19. Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988;26:724-35.
20. Hoffman GS, Drucker Y, Cotch MF, Locker GA, Easley K, Kwoh K. Wegener's granulomatosis: Patient-reported effects of disease on health, function, and income. Arthritis Rheum 1998;41:2257-62.
21. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987;42:773-8.
22. Ries A, Carlin BW, Carrieri-Kohlman V et al. Pulmonary rehabilitation: evidence based guidelines. Chest 1997;112:1363-96.
23. Martens J, Demedts M, Vanmeenen MT, Dequeker J. Respiratory muscle dysfunction in systemic lupus erythematosus. Chest 1983; 84:170-5.